US20160287439A1 - Non-invasively adjustable drainage device - Google Patents
Non-invasively adjustable drainage device Download PDFInfo
- Publication number
- US20160287439A1 US20160287439A1 US15/019,890 US201615019890A US2016287439A1 US 20160287439 A1 US20160287439 A1 US 20160287439A1 US 201615019890 A US201615019890 A US 201615019890A US 2016287439 A1 US2016287439 A1 US 2016287439A1
- Authority
- US
- United States
- Prior art keywords
- turnable
- container
- inlet tube
- adjustable drainage
- opening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/0013—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting fluid pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0069—Sealing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3507—Communication with implanted devices, e.g. external control
- A61M2205/3515—Communication with implanted devices, e.g. external control using magnetic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
- F16K3/00—Gate valves or sliding valves, i.e. cut-off apparatus with closing members having a sliding movement along the seat for opening and closing
- F16K3/30—Details
- F16K3/34—Arrangements for modifying the way in which the rate of flow varies during the actuation of the valve
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
Abstract
The device comprises at least an inlet tube for the passage of fluid to be drained, said tube being connected to a chamber wherein said chamber comprises rotating means for adjusting the flow rate in said tube.
Description
- This application is continuation of U.S. application Ser. No. 12/743,955, filed Oct. 18, 2010, which is a national stage application under 35 U.S.C. 371 of PCT Application No. PCT/IB2007/054771 having an international filing date of 23 Nov. 2007, which designated the United States, the entire disclosure of which is incorporated herein by reference.
- The present invention concerns an implantable adjustable drainage device for draining body fluids. More specifically, the present invention concerns a non-invasively adjustable drainage device used for example for the treatment of glaucoma.
- Implantable adjustable drainage devices are known in the art, especially in the field of treatment of glaucoma.
- Glaucoma is a disorder associated with high pressure in the eye, and is characterized by damage to the optic nerve, with consequent visual loss, initially peripheral, but potentially blinding if relentlessly progressive. Unfortunately, glaucoma is usually a disease in which the patient is entirely asymptomatic (without symptoms) until late in the disease. Glaucoma affects about 70 millions of people worldwide.
- While traditional treatment of glaucoma is through medication for example eye drops lowering the production of intraocular fluid (aqueous humor), in certain cases this treatment fails and other surgical treatments are preferred, such as filter procedures or placement of a glaucoma drainage device (“GDD”) with a drainage tube. GDDs help evacuate intraocular fluid by providing an artificial drainage pathway, thus maintaining a low intraocular pressure (“IOP”).
- Typically, the GDD is inserted through a small incision made in the conjunctiva. The surgeon then makes a tiny incision in the sclera of the eye and fashions an opening for the drainage implant device. The drainage tube is placed such that the opening of the tiny tube is inside the anterior chamber of the eye where it is bathed in aqueous fluid. The tube is sutured in place with the drainage device attached to the sclera of the eye. Most surgeons will place an absorbable suture around the tube at the time of surgery to prevent filtration through the device until a fibrous capsule has formed. As such, the device is not expected to function until about 3 to 8 weeks following the procedure. This technique is thought to prevent over-filtration.
- A glaucoma passive drainage device of the prior art is described in U.S. Pat. No. 4,457,757 to Molteno. The Molteno device comprises in particular a tube made of a biologically inert silicone tubing for insertion into the eye in order to drain the aqueous humor from the anterior chamber of the eye. This device does not have a pressure regulating mechanism and only relies on the pressure regulation provided by the resistance to aqueous flow of the tubing.
- One of the major problems of such device is that it is totally passive, i.e., the drainage flow depends on IOP and on the fixed hydrodynamic resistance of the shunt. In many cases, however, the hydrodynamic resistance of the shunt may not be optimal which may lead to high IOP, when the resistance is high, or to over-drainage, if the resistance is low.
- This problem has been recognised in the prior art and several publications relate to improvements of the known device such that the flow can be controlled and adapted.
- Another example is illustrated in U.S. Pat. No. 5,411,473 to Ahmed. In this patent, the idea is to add a system to a drainage device, in which the system has a membrane folded and held in tension between two plates to provide a slit opening. The membrane responds to pressure changes to open or close the slit opening. All the characteristics of the system are based on the properties of the membrane itself and this element cannot be changed easily.
- Another example is illustrated in U.S. Pat. No. 5,300,020 to L'Esperance where the drainage system comprises flow control means. In this patent, said means are in the form of a plug of absorbable material having porous properties which maintains anterior chamber pressure. Once the aqueous fluid has been totally absorbed into the plug, a path of relatively slow drainage flow will be established into the subconjunctival space until an equilibrium of pressures is developed. The pressure release is slow enough to avoid a collapse of the cornea yet sufficient to lower the intraocular pressure.
- As one will readily understand, a disadvantage of this solution is that it has certain inertia and the flow rate may not be changed to adapt to the circumstances.
- In another embodiment disclosed in this patent, the system comprises a flexible drainage tube with a time-delay valve-opening structure. This structure comprises a ball of biocompatible absorbable material as means of applying a valve-closing squeeze on the tube. As the body fluid gradually dissolve the material of the ball, the valve-closing force of the ball is reduced to create a valve opening condition. In a further embodiment, the valve-opening structure comprises polymer components which either inherently or by reason of special compounding are selectively shrinkable or stretchable to effect opening and/or closure operation of the valve device.
- In this embodiment, it is clear that a precise adjustment of the flow rate of the drainage is difficult to realize over time and once the ball has dissolved, it is not possible to regulate the flow anymore.
- Other examples are disclosed in the following prior art publications U.S. Pat. No. 5,626,558, U.S. Pat. No. 6,186,974, U.S. Pat. No. 6,508,779 or U.S. Pat. No. 6,726,664.
- U.S. Pat. No. 6,077,299 to Adelberg et al. discloses a non-invasively adjustable valve implant for the drainage of aqueous humor in glaucoma. An aim of the device disclosed in this patent is to provide an implant with a flow characteristic that can be adjusted in a non-invasive manner. More specifically, this device comprises an implant with an inlet tube that is surgically inserted in the anterior chamber of the eye allowing aqueous humor to flow from the anterior chamber to a valve. After passing through the pressure and/or flow regulating valve in the implant, the fluid is dispersed along the periphery of the implant to the interior of the Tenon's capsule where it is absorbed by the body. In one embodiment, the valve inhibits flow below and allows flow above a specific pressure difference between the intraocular pressure within the eye and the pressure within the bleb cavity in Tenon's capsule. The specified pressure difference or set-point is always positive and the valve is always closed for negative pressure differences to prevent reverse flow of fluid from the Tenon's capsule back into the anterior chamber of the eye.
- In this patent, the valve is formed by a chamber to which the inlet tube is connected, said chamber being closed by pressure sensitive valve made of a flexible material, such as silicone, in the shape of a flat cone. The pressure regulation set point of the valve is governed by a flexible diaphragm cooperating with an armature plate having an inclined surface configured to slide over a complementary inclined surface that is attached to the diaphragm. The cooperation of the inclined surface of the plate and the complementary surface causes the diaphragm to deflect depending on where the armature plate is located. The armature plate itself is rotated to carry out this regulation through a rotor and a set of speed-reducing and torque-enhancing gears.
- As one will readily understand, the characteristics of the valve depend strongly on one element that is the cone shaped valve. In addition, the regulating mechanism comprises many rotating parts and gears rendering it rather complicated to fabricate. In addition, because of the high number of moving parts, there is also a risk of malfunction of the device.
- U.S. Pat. No. 6,168,575 and U.S. Pat. No. 6,589,198 to Soltanpour et al. disclose micro-pump assemblies that can be implanted in the eye for controllably removing excess fluid from the eye in order to treat glaucoma. In these patents, the implanted pumps have a variable pumping rate that can be adjusted either manually or automatically, controlled by the measured intra-ocular pressure. The disadvantage of such device is in particular the fact that they are complicated and expensive. Indeed, the device must contain all the necessary elements, in particular electronics and power source and since the device is implanted, these elements must be small and contained in a sealed enclosure. The risk of malfunction is also increased because of the high number of different elements present that must cooperate together.
- Accordingly, an aim of the present invention is to improve the known devices and system.
- Another aim of the present invention is to provide a GDD device that is simple to operate, using a reduced number of parts.
- A further aim of the present invention is to provide a GDD device that is easy and cheap to fabricate.
- The present invention will be better understood from the description of several embodiments and from the following drawings in which:
-
FIG. 1 illustrates an exploded perspective view of a first embodiment of the invention; -
FIG. 2 illustrates an example of an external control device used in connection with embodiments of the invention; -
FIG. 3A illustrates a perspective view of a second embodiment of the invention; -
FIG. 3B illustrates an exploded perspective view of the embodiment ofFIG. 3A ; -
FIG. 3C illustrates a cross-section perspective view of the tube container assembly as illustrated inFIG. 3B ; -
FIG. 4 illustrates an alternative embodiment of the invention utilized inside the tube container assembly; -
FIG. 5 illustrates a cross-sectional view of a further embodiment of the invention; -
FIG. 6A illustrates a perspective view of another embodiment of the invention; -
FIG. 6B illustrates an exploded perspective view of the embodiment ofFIG. 6A ; -
FIG. 6C illustrates a cross-section perspective view of the tube container assembly as illustrated inFIG. 6B . - In the following description reference will be mainly made to a device that can be used as a GDD (glaucoma drainage device). However, this should not be construed as limiting and other drainage applications may be envisaged for the device according to the invention.
- In
FIG. 1 a schematic diagram of first embodiment of the device is represented. According to the invention, the principle is to adjust the hydrodynamic resistance of the device by means of a rotating disk, which encompasses a variable-section for the passage of fluid. As the disk rotates, clockwise or counterclockwise, the section increases or decreases and the resistance decreases or increases, respectively. To this effect, the device comprises an inlet tube 1, which drains the fluid from the eye (or any other part to be drained) into a hollowshallow container 2. The container is closed hermetically with a gasket 4, which comprises a variable section slit 5 through which fluid can flow from the exit of the tube 3 into the container and thereafter into the outer space through exit holes 6. The gasket 4, although hermetically sealing the container, can rotate around its axis, which is also the axis of rotational symmetry of the container. According to the invention, the rotation of the gasket 4 changes the relative position of the slit 5 with respect to the tube exit 3, thereby imposing a variable resistance to fluid flow. When the gasket is rotated counterclockwise (viewed from the top), the slit section in front of the tube exit 3 decreases, thereby increasing flow resistance, whereas when the rotation is clockwise the slit section increases and resistance to fluid flow decreases. - As one can readily understand, the principle of the system is far simpler than the known device cited above.
- It is also necessary to provide means for actuating the rotation of the gasket preferably non-invasively. In order to have a tele-controllable system, one uses, in one embodiment, an applied directional external magnetic field. The proposed procedure and means for achieving this effect are the following: the gasket comprises a permanent magnet 7 that creates a magnetic field, which can easily be detected by placing an external device (i.e. a sensing device) on top of the patient's eye. The sensing device contains a number of sensors, such as magnetoresistive sensors or other equivalent devices, which can sense the magnetic field. The information from the sensors can be combined with the magnetic field equations to derive the amplitude and direction of the magnetic field. This allows the precise determination of the direction of the magnet 7 and, by way of consequence, the rotational position of the gasket 4.
- Once the direction of the magnet 7 is known, the user can impose a given rotation to the gasket, and thereby change the position of the gasket 4, by applying a strong external magnetic field, which is oriented at a given angle with respect to the actual angle of the magnet 7.
- This is illustrated schematically in
FIG. 2 . The strong magnetic field will impose a torque on the magnet, which is proportional to the amplitude of the magnetic field times the magnetic moment of the magnet 7. The torque will force the magnet 7 to align with the imposed magnetic field, thereby imposing a rotation of the gasket equal to the difference in the angles between the original magnet direction and the direction of the imposed magnetic field. With this method, an operator can impose precise and measurable rotations to the gasket, thus obtaining the desired changes in fluidic resistance in the draining device. - Magnetoresistive sensors 9 are placed on a rim 8, which is positioned on top of the patient's eye. The sensors are used to capture and compute the direction of the underlying magnet 7, which is displayed as the vector oriented to the left on the
control unit 11 screen. If the user wishes to rotate the gasket 4 by an angle Θ clockwise, he/she turns theelectromagnet 10 such that its direction illustrated by the vector oriented to the right on thecontrol unit 11 screen forms the desired angle Θ with the magnet angle. The user then powers theelectromagnet 10, which applies a strong magnetic field with a polarity opposite to that of the magnet and in the direction of the vector oriented to the right. The induced magnetic field applies a strong torque on the underlying magnet 7, which forces the magnet 7 to align with the vector oriented to the right, thus achieving the desired gasket rotation. - In another equivalent design, the
rotational electromagnet 10 can be replaced by two fixed orthogonal electromagnets. Upon activation, each of the two orthogonal electromagnets will deliver a magnetic field oriented along its axis. The total magnetic field will be the vector sum of the two individual fields. By choosing the relative intensity of the current fed into each of the electromagnets one can deliver a magnetic field of any desired magnitude and orientation. - Fluidic resistance can be measured for the different rotational positions of the gasket, thereby providing some a priori guidance to the user for selecting the amplitude of rotation needed for obtaining a desired effect on the drainage and the resulting IOP. Otherwise, the user may apply incremental rotations and measure every time the IOP for verifying the optimal position of the gasket 4.
- Another embodiment of the invention is illustrated in
FIG. 3 . In this embodiment thetube 12 which is inserted into the intraocular space and acts as fluid conduit is connected to acontainer 13 either at an normal angle or, in general, at an oblique angle as shown inFIG. 3 . The base of thecontainer 13 in contact with the eye is either flat or has a slight spherical curvature, with a radius of curvature of typically 11 mm or similar, which corresponds to the natural radius of curvature of the eye. This curvature is seen inFIG. 3C . - In
FIG. 3 , “A” shows an assembled view of this embodiment of the invention. “B” an exploded view of the device where theinternal plate 17 containing the variable section slit 16 and themagnet 18 is seen. “C” A section view of the tube-container assembly with a longitudinal cut through thetube 12 showing thecanal 14 through which fluid flows. - The fluid will drain through
canal 14 and will exit through theexit hole 15 and the superposed slit 16 into the inner cavity of thecontainer 13, from where it will finally exit throughholes 20 into the external space. As in the first mode of realization, the change in fluidic resistance is achieved by rotatingplate 17 via the rotation imposed on themagnet 18 through the external magnetic field.Plate 17 is assembled so that is kept under some pressure against the base of the inner cavity of the container 13 (for example through a spring), leaving thus no space for the fluid to exit from thetube 12 other than through theslit 16. Hence, it is the relative position of theslit 16 with respect tohole 15 which determines what is the effective size of the exit hole, thus determining also the effective fluidic resistance of the system according to the principle of the invention. Preferably, theplate 17 has an axis (not shown) which penetrated into a hole of thecontainer 13 to ensure proper relative rotation. - In another design illustrated in
FIG. 4 ,plate 17 may contain a plurality ofholes 21 as opposed to the variable section slit 16. The holes have a progressively smaller diameter and are spaced on a circular arc with respect to the axis of rotation in a manner such that as the disk is rotated by a given angle ΔΘ, one of theholes 21 will be on top and concentric with theexit hole 15. The angle of rotation between two successive holes ΔΘ, is drawn here to be 30 degrees, but this can vary according to the number of holes and the desired resolution (fine regulation) in the change in fluidic resistance that one likes to achieve. To insure a rotation by increments of exactly the angle ΔΘ, theplate 17 may comprise on its axis of rotation or in the periphery a “gear-like” system or equivalent system, which allows rotational steps of exactly the angle ΔΘ. An example, among others, of such system is shown inFIG. 4 . The dodecagonal “gear” 22 is concentric and attached to theplate 17. The stiff butflexible beam 23 is fixed to the wall of thecontainer 13 and is pushing on one of the flat surfaces of dodecagonal “gear” 22 with a certain force F. Any rotation of theplate 17 less than ΔΘ will force the beam to be deflected to the left, increasing thus the contact force F. The contact force F will be restored into its minimum level when a rotation of exactly ΔΘ is achieved. - Such a system guarantees two important functionalities:
-
- 1) It forces the system to take a position at the point of minimal energy, thereby guaranteeing that a rotation of exactly ΔΘ or multiples of that are performed.
- 2) It prevents accidental rotations of the plate due to external mechanical factors (i.e., physiological movements, shocks, variations in external magnetic fields, etc.).
- It is clear that accidental or undesired rotation of the
plate 17 due to variation of external magnetic fields (i.e., variations in the terrestrial magnetic field, etc.) may be prevented by correctly dimensioning the required applied magnetic field by means of theelectromagnet 10, so that the latter is much greater than the naturally occurring external magnetic fields and sufficient enough to: a) overcome the frictional forces between theplate 17 and the bottom surface ofcontainer 13 and b) provide enough energy (moment) to flex thebeam 23 and carry out the desired rotation. - It is evident that a similar system of successive holes can also replace the variable section slit 5 in
FIG. 1 . Further, a “gear” or other equivalent mechanical system similar the one explained earlier, which limits accidental rotations of the gasket 4, may also be included in the device shown inFIG. 1 . - In another embodiment, the device according to the invention can include a miniaturized pressure sensor along the
fluidic channel 14, preferably as close to the intraocular space as possible, connected to a miniaturized telemetry system which can be activated and energized from distance and which can send to an external receiver, telemetrically, the measured IOP signal. This feature will allow for an easy and non-invasive measurement of IOP. - The principle of the invention, i.e. sense the direction of magnetic fields within implanted devices and applying magnetic fields to move, position or rotate parts of said implanted devices can be of general utility for a variety of medical devices. One such example is the control of fluid flow within bodily conduits, such as vessels (veins or arteries) or other ducts (i.e., urinary duct, etc). An example of a further embodiment of the invention illustrating this principle is shown in
FIG. 5 . - In this design, the device containing an
outer shell 24 connected through ahinge 26 to aclip 25 can be positioned around avessel 27 so that the vessel is contained in the space between theclip 25 and a flexible and/orelastic membrane 28, which covers hermetically the device and prevents any contact of the internal mechanism of the device with the external fluids and tissues. Theclip 25 is secured in place by alocking system 31. An elliptic-shapedcylinder 30 containing amagnet 29 can be rotated or positioned via applied external magnetic fields, as explained earlier, thereby pressing at variable degrees on themembrane 28, depending on its rotational position, and thus imposing variables degrees of constriction on the arterial cross sectional area. This, in turn, will lead to changes in hemodynamical resistance and control of flow. It is evident to any knowledgeable person in the field that the shape of theclip 25 and the rotating elliptic-shapedcylinder 30 can be chosen so as to optimize the effects of rotation on the shape of the contained vessel, to achieve optimal results (i.e., linear or prescribed change in cross-sectional area of the vessel per degree of rotation, etc.). - In addition, this embodiment may be used in the device illustrated in
FIG. 1 whereby thevessel 27 ofFIG. 5 will be replaced by the inlet tube 1 to obtain the same regulation effect. - Also, it is possible to use a system equivalent to the
gear 22 andbeam 23 ofFIG. 4 in order to carry out definite rotation of a given angle instead of continuous variations. - In a further embodiment, it is possible to apply the principle of the invention on the exit holes 6 (see
FIG. 1 ) or 20 (seeFIG. 3 ) and limit the flow leaving thechamber FIG. 3 where one or more exit holes 20 may be opened to limit or increase the flow leaving thecontainer 13. - In a further embodiment, instead of varying the section of the slit or the diameter of the holes, one could envisage to use a porous media with variable porosities. For example, all holes could have the same diameter and be covered with a sheath or other biocompatible fabric with different porosity. Another possibility, as illustrated in
FIG. 6B , is to have acontinuous slit 16 of constant width, but have the slit covered with a sheath or fabric 32 or equivalent surface with a gradually changing porosity. For example, the change of porosity could be made by the addition oflayers - In a variant, the slit or the holes could also change size even with such porous media added. This could allow a finer regulation of the flow.
- Of course, the embodiments described above are non-limiting illustrative examples and variations using equivalent means are possible.
Claims (14)
1.-11. (canceled)
12. An adjustable drainage implantable device comprising:
an inlet tube for a passage of a fluid to be drained;
a container having an inlet opening and an outlet opening, an interior of the container connected to the inlet tube via the inlet opening, the outlet opening allowing the drained fluid to exit the container; and
a turnable device having a variable-shaped opening to provide a variable resistance to a fluid flow at least at one of the inlet opening and the outlet opening of the container, the turnable device configured to be turned relative to the container such that different relative angular positions of the turnable device towards the container impose different fluid flow resistances.
13. The adjustable drainage implantable device as defined in claim 12 , wherein the variable-shaped opening is a longitudinal slit with a variable cross-section.
14. The adjustable drainage implantable device as defined in claim 12 , wherein the variable-shaped opening is a porous media with gradually changing porosity.
15. The adjustable drainage implantable device as defined in claim 12 , wherein the turnable device further forms a gasket for sealing the interior of the container but for the inlet opening and the outlet opening.
16. The adjustable drainage implantable device as defined in claim 12 , further comprising:
a gear device connected to the turnable device, the gear device configured to change an angular position of the turnable device in a step-wise fashion.
17. The adjustable drainage implantable device as defined in claim 16 , further comprising:
a flexible beam applying a force to the gear device such that the turnable device is held by the flexible beam and the gear device to a defined angular position relative to the container.
18. The adjustable drainage implantable device as defined in claim 16 , further comprising:
a permanent magnet fixed to the turnable device for changing the angular position of the gear device by a magnetic field by a device that is external to the adjustable drainage implantable device.
19. A system for draining bodily fluids, comprising:
an inlet tube for a passage of a fluid to be drained;
a container having an inlet opening and an outlet opening, an interior of the container connected to the inlet tube via the inlet opening, the outlet opening allowing the drained fluid to exit the container;
a turnable device having a variable-shaped opening to provide a variable resistance to a fluid flow at least at one of the inlet opening and the outlet opening of the container, the turnable device configured to be turned relative to the container such that different relative angular positions of the turnable device towards the container impose different fluid flow resistances;
a detector for determining an angular position of the turnable device; and
positioning means for positioning the turnable device to adjust the flow rate in the inlet tube.
20. The system of claim 19 , further comprising:
a permanent magnet fixedly attached to turnable device,
wherein the detector includes a magnetoresistive sensor for detecting an angular position of the permanent magnet, and the positioning means includes an electromagnet for aligning the permanent magnet, the detector and the positioning means not being in contact with the turnable device.
21. The system of claim 19 , wherein the detector includes a rim, and the magnetoresistive sensors are mounted on the rim.
22. A system for draining bodily fluids, comprising:
an adjustable drainage implantable device including,
an inlet tube for a passage of a fluid to be drained, and
a container forming a chamber connected to the inlet tube, the chamber having a turnable device for adjusting the flow rate in the inlet tube by directly engaging the inlet tube via a membrane, the membrane directly engaging the inlet tube, and the turnable device having a body that presses at variable degrees on the membrane depending on an angular position of the turnable device and thus imposes continuously variable degrees of constriction on a sectional area of the inlet tube;
a control device external to the adjustable drainage implantable device, the control device including,
a detector for determining the position of the turnable device, and
positioning means for positioning the turnable device to adjust the flow rate of the inlet tube.
23. The system of claim 22 , wherein the turnable device further includes a permanent magnet for detecting and adjusting the angular position of the turnable device, and wherein
the detector includes magnetoresistive sensors for detecting the angular position of the permanent magnet and the positioning means includes an electromagnet for aligning the permanent magnet.
24. The system of claim 23 , wherein the detector comprises a rim and the magnetoresistive sensors are mounted on the rim.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/019,890 US20160287439A1 (en) | 2007-11-23 | 2016-02-09 | Non-invasively adjustable drainage device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/743,955 US9375347B2 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
PCT/IB2007/054771 WO2009066133A1 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
US15/019,890 US20160287439A1 (en) | 2007-11-23 | 2016-02-09 | Non-invasively adjustable drainage device |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/054771 Continuation WO2009066133A1 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
US12/743,955 Continuation US9375347B2 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160287439A1 true US20160287439A1 (en) | 2016-10-06 |
Family
ID=39508864
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/743,955 Active US9375347B2 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
US15/019,890 Abandoned US20160287439A1 (en) | 2007-11-23 | 2016-02-09 | Non-invasively adjustable drainage device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/743,955 Active US9375347B2 (en) | 2007-11-23 | 2007-11-23 | Non-invasively adjustable drainage device |
Country Status (6)
Country | Link |
---|---|
US (2) | US9375347B2 (en) |
EP (2) | EP2214769B1 (en) |
JP (1) | JP5390531B2 (en) |
CN (1) | CN101918071B (en) |
ES (1) | ES2410430T3 (en) |
WO (1) | WO2009066133A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019195419A1 (en) | 2018-04-03 | 2019-10-10 | Jack Chu | A new ocular device and method for glaucoma treatment |
WO2021163566A1 (en) * | 2020-02-14 | 2021-08-19 | Shifamed Holdings, Llc | Shunting systems with rotation-based flow control assemblies, and associated systems and methods |
US11166849B2 (en) | 2017-07-20 | 2021-11-09 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
US11166848B2 (en) | 2017-07-20 | 2021-11-09 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
US11517477B2 (en) | 2019-10-10 | 2022-12-06 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
US11529258B2 (en) | 2020-01-23 | 2022-12-20 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
US11596550B2 (en) | 2020-04-16 | 2023-03-07 | Shifamed Holdings, Llc | Adjustable glaucoma treatment devices and associated systems and methods |
US11737920B2 (en) | 2020-02-18 | 2023-08-29 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts having non-linearly arranged flow control elements, and associated systems and methods |
US11766355B2 (en) | 2020-03-19 | 2023-09-26 | Shifamed Holdings, Llc | Intraocular shunts with low-profile actuation elements and associated systems and methods |
US11865283B2 (en) | 2021-01-22 | 2024-01-09 | Shifamed Holdings, Llc | Adjustable shunting systems with plate assemblies, and associated systems and methods |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ20013823A3 (en) | 1999-04-26 | 2002-03-13 | Gmp Vision Solutions, Inc. | Stent device and method for treating glaucoma |
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
CA2683224C (en) | 2001-04-07 | 2014-12-02 | Glaukos Corporation | System and methods thereof for treatment of ocular disorders |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US7331984B2 (en) | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
EP2088976B1 (en) | 2006-11-10 | 2019-07-03 | Glaukos Corporation | Uveoscleral shunt |
US10603214B2 (en) | 2011-01-14 | 2020-03-31 | Ecole Polytechnique Federale De Lausanne (Epfl) | Apparatus and methods for treating excess intraocular fluid |
ES2528350T3 (en) * | 2011-01-14 | 2015-02-09 | Ecole Polytechnique Federale De Lausanne (Epfl) | Apparatus and method for the treatment of excess intraocular fluid |
WO2013148275A2 (en) | 2012-03-26 | 2013-10-03 | Glaukos Corporation | System and method for delivering multiple ocular implants |
KR102210125B1 (en) | 2012-06-21 | 2021-02-01 | 메드트로닉 좀드 인코퍼레이티드 | Fluid flow control devices, rotors and magnets with increased resistance to inadvertent setting change and improved accessory tool coupling |
US9126010B2 (en) | 2013-03-14 | 2015-09-08 | Medtronic Xomed, Inc. | Device and method for finding the center and reading the setting of an implantable medical device |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
CN103919643A (en) * | 2014-04-01 | 2014-07-16 | 齐文华 | Postoperative sclera flap adhesion preventive device for anti-glaucoma operation |
EP3148491B1 (en) | 2014-05-29 | 2020-07-01 | Glaukos Corporation | Implants with controlled drug delivery features and manufacturing method for said implants |
CN104490515A (en) * | 2014-12-18 | 2015-04-08 | 肖真 | Glaucoma valve and glaucoma drainage device |
US9655778B2 (en) | 2015-07-13 | 2017-05-23 | Thomas D. Tyler | Position responsive flow adjusting implantable device and method |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US10596035B2 (en) | 2016-06-06 | 2020-03-24 | Ecole Polytechnique Federale De Lausanne (Epfl) | Apparatus for treating excess intraocular fluid |
WO2019051475A1 (en) * | 2017-09-11 | 2019-03-14 | Oregon Health & Science University | Glaucoma tube implant with modulated flow |
US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
EP3583892A1 (en) * | 2018-06-20 | 2019-12-25 | Koninklijke Philips N.V. | Pressure sensing unit, system and method for remote pressure sensing |
CN110522556B (en) * | 2019-08-30 | 2021-07-13 | 华中科技大学同济医学院附属同济医院 | Front-mounted adjustable electromagnetic drainage valve for treating glaucoma |
WO2021176332A1 (en) | 2020-03-06 | 2021-09-10 | Ecole Polytechnique De Lausanne (Epfl) | Apparatus for treating excess intraocular fluid having an elastic membrane |
WO2023081356A1 (en) * | 2021-11-05 | 2023-05-11 | W. L. Gore & Associates, Inc. | Fluid drainage devices, systems, and methods |
WO2023081365A1 (en) * | 2021-11-05 | 2023-05-11 | W. L. Gore & Associates, Inc. | Fluid drainage devices, systems, and methods |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4515588A (en) * | 1983-05-16 | 1985-05-07 | Health Care Concepts, Inc. | I.V. flow regulator |
US5308040A (en) * | 1991-11-28 | 1994-05-03 | Torres Nestor Ruben | Fluid flow regulating valve |
US6050969A (en) * | 1998-04-17 | 2000-04-18 | Johnson & Johnson Professional, Inc. | Pressure indicator |
US20050085763A1 (en) * | 2002-08-02 | 2005-04-21 | Alec Ginggen | Adjustable resistance valve for a cerebrospinal fluid shunt system |
US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
US20060027777A1 (en) * | 2004-08-03 | 2006-02-09 | Harris Corporation | Embedded control valve using homopolar motor |
US20100152524A1 (en) * | 2006-08-31 | 2010-06-17 | Smartin Technologies, Inc. | Modular magneto mechanical device |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3926175A (en) * | 1974-06-03 | 1975-12-16 | James H Allen | Implantable valve for medical purposes |
DE2626215C3 (en) * | 1976-06-11 | 1979-03-01 | Messerschmitt-Boelkow-Blohm Gmbh, 8000 Muenchen | Drainage device for draining excess fluid from the cerebral cavities |
US4140011A (en) * | 1977-05-31 | 1979-02-20 | The Regents Of The University Of Minnesota | Automatic precipitation sampler |
US4457757A (en) * | 1981-07-20 | 1984-07-03 | Molteno Anthony C B | Device for draining aqueous humour |
US5071408A (en) * | 1988-10-07 | 1991-12-10 | Ahmed Abdul Mateen | Medical valve |
US5300020A (en) | 1991-05-31 | 1994-04-05 | Medflex Corporation | Surgically implantable device for glaucoma relief |
GB2285303B (en) * | 1993-12-31 | 1997-07-23 | Hwang Shao Keh | Magnetic control-type flow control valve |
US5626558A (en) | 1995-05-05 | 1997-05-06 | Suson; John | Adjustable flow rate glaucoma shunt and method of using same |
GB9700390D0 (en) | 1997-01-10 | 1997-02-26 | Biocompatibles Ltd | Device for use in the eye |
US6168575B1 (en) * | 1998-01-29 | 2001-01-02 | David Pyam Soltanpour | Method and apparatus for controlling intraocular pressure |
US6589198B1 (en) | 1998-01-29 | 2003-07-08 | David Soltanpour | Implantable micro-pump assembly |
US6090062A (en) * | 1998-05-29 | 2000-07-18 | Wayne State University | Programmable antisiphon shunt system |
US6077299A (en) | 1998-06-22 | 2000-06-20 | Eyetronic, Llc | Non-invasively adjustable valve implant for the drainage of aqueous humor in glaucoma |
US6558342B1 (en) | 1999-06-02 | 2003-05-06 | Optonol Ltd. | Flow control device, introducer and method of implanting |
JP3852734B2 (en) * | 1999-12-20 | 2006-12-06 | セイコーインスツル株式会社 | Pressure variable valve device and set pressure adjusting device for the valve device |
DE10113823A1 (en) * | 2001-03-21 | 2002-09-26 | Seiko Instr Inc | Pressure control valve device and device for setting the desired pressure of the valve |
JP4328688B2 (en) * | 2004-07-26 | 2009-09-09 | 株式会社カネカメディックス | Subcutaneous body fluid flow controller |
US7334594B2 (en) * | 2005-06-29 | 2008-02-26 | Codman & Shurtleff, Inc. | Apparatus and method for adjusting a locking mechanism of a shunt valve |
US8469331B2 (en) * | 2006-04-07 | 2013-06-25 | Nxstage Medical, Inc. | Filtration system for preparation of fluids for medical applications |
CN101466299B (en) * | 2006-04-26 | 2011-11-02 | 东弗吉尼亚医学院 | Systems and methods for monitoring and controlling internal pressure of an eye or body part |
EP2088976B1 (en) * | 2006-11-10 | 2019-07-03 | Glaukos Corporation | Uveoscleral shunt |
-
2007
- 2007-11-23 EP EP07849238A patent/EP2214769B1/en active Active
- 2007-11-23 WO PCT/IB2007/054771 patent/WO2009066133A1/en active Application Filing
- 2007-11-23 JP JP2010534553A patent/JP5390531B2/en active Active
- 2007-11-23 CN CN200780101682.3A patent/CN101918071B/en active Active
- 2007-11-23 EP EP11187738A patent/EP2417946A1/en not_active Withdrawn
- 2007-11-23 ES ES07849238T patent/ES2410430T3/en active Active
- 2007-11-23 US US12/743,955 patent/US9375347B2/en active Active
-
2016
- 2016-02-09 US US15/019,890 patent/US20160287439A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4515588A (en) * | 1983-05-16 | 1985-05-07 | Health Care Concepts, Inc. | I.V. flow regulator |
US5308040A (en) * | 1991-11-28 | 1994-05-03 | Torres Nestor Ruben | Fluid flow regulating valve |
US6050969A (en) * | 1998-04-17 | 2000-04-18 | Johnson & Johnson Professional, Inc. | Pressure indicator |
US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
US20050085763A1 (en) * | 2002-08-02 | 2005-04-21 | Alec Ginggen | Adjustable resistance valve for a cerebrospinal fluid shunt system |
US20060027777A1 (en) * | 2004-08-03 | 2006-02-09 | Harris Corporation | Embedded control valve using homopolar motor |
US20100152524A1 (en) * | 2006-08-31 | 2010-06-17 | Smartin Technologies, Inc. | Modular magneto mechanical device |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11166849B2 (en) | 2017-07-20 | 2021-11-09 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
US11166848B2 (en) | 2017-07-20 | 2021-11-09 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
WO2019195419A1 (en) | 2018-04-03 | 2019-10-10 | Jack Chu | A new ocular device and method for glaucoma treatment |
US11446179B2 (en) | 2018-04-03 | 2022-09-20 | Jack Chu | Ocular device and method for glaucoma treatment |
US11517477B2 (en) | 2019-10-10 | 2022-12-06 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
US11529258B2 (en) | 2020-01-23 | 2022-12-20 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
WO2021163566A1 (en) * | 2020-02-14 | 2021-08-19 | Shifamed Holdings, Llc | Shunting systems with rotation-based flow control assemblies, and associated systems and methods |
US11291585B2 (en) | 2020-02-14 | 2022-04-05 | Shifamed Holdings, Llc | Shunting systems with rotation-based flow control assemblies, and associated systems and methods |
US11737920B2 (en) | 2020-02-18 | 2023-08-29 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts having non-linearly arranged flow control elements, and associated systems and methods |
US11766355B2 (en) | 2020-03-19 | 2023-09-26 | Shifamed Holdings, Llc | Intraocular shunts with low-profile actuation elements and associated systems and methods |
US11596550B2 (en) | 2020-04-16 | 2023-03-07 | Shifamed Holdings, Llc | Adjustable glaucoma treatment devices and associated systems and methods |
US11865283B2 (en) | 2021-01-22 | 2024-01-09 | Shifamed Holdings, Llc | Adjustable shunting systems with plate assemblies, and associated systems and methods |
Also Published As
Publication number | Publication date |
---|---|
WO2009066133A1 (en) | 2009-05-28 |
US20110066098A1 (en) | 2011-03-17 |
CN101918071A (en) | 2010-12-15 |
EP2214769A1 (en) | 2010-08-11 |
US9375347B2 (en) | 2016-06-28 |
CN101918071B (en) | 2016-11-16 |
EP2214769B1 (en) | 2013-03-13 |
EP2417946A1 (en) | 2012-02-15 |
ES2410430T3 (en) | 2013-07-01 |
JP5390531B2 (en) | 2014-01-15 |
JP2011504392A (en) | 2011-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9375347B2 (en) | Non-invasively adjustable drainage device | |
US11712371B2 (en) | Apparatus and methods for treating excess intraocular fluid | |
JP6330014B2 (en) | Apparatus and method for treating excess intraocular fluid | |
US10596035B2 (en) | Apparatus for treating excess intraocular fluid | |
US4402681A (en) | Artificial implant valve for the regulation of intraocular pressure | |
US7118549B2 (en) | Shunt system including a flow control device for controlling the flow of cerebrospinal fluid out of a brain ventricle | |
US11779489B2 (en) | Apparatus for treating excess intraocular fluid having an elastic membrane | |
CN112689488B (en) | Device for treating excess intraocular fluid with elastic membrane | |
JPH11146911A (en) | Shunt valve | |
Villamarin et al. | A new adjustable glaucoma drainage device | |
JP2006512139A (en) | Gravity pressure adjustment mechanism | |
CN105919723A (en) | Non-invasive adjustable drainage equipment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL), S Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STERGIOPULOS, NIKOLAOS;REEL/FRAME:038955/0510 Effective date: 20100817 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |